Teva Offers EU Concessions Over Allergan Generics Deal

According to Reuters.com, “Teva Pharmaceutical Industries Ltd has offered concessions to allay EU antitrust concerns over its $40.5 billion bid for Allergan’s generics unit which will cement its position as the world’s largest generics...

Allergan and AstraZeneca Commit to Antibiotic Development Deal

According to Genengnews.com, “Dublin-based Allergan has entered into an agreement with AstraZeneca to develop and commercialize a fixed-dose antibiotic formulation currently in Phase II study. The financial terms of the agreement were not detailed, though...